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Abstract 
Autoimmune disorders (AD) are a group of highly disabling pathological conditions that are 
growing at an alarming rate affecting approximately 8% of the population. These disorders occur 
more frequently in women, as 78% of those diagnosed are women. Little conclusive research has 
been conducted as to determine why there is a tremendous sex disparity when looking at the 
rates. Due to the overall poor health that results from these disorders, there is an increase in the 
societal burden in terms of health care costs, loss of work productivity and reduced quality of 
life. The aim of this integrative literature review was to determine the reason for the sex disparity 
in autoimmune disorders and to determine the collective disease burden of these disorders on 
women. From this review, a determination will be made as to what education and preventative 
measure are being directed towards women in an attempt to decrease autoimmune rates. The 
literature search for the presented topic was found in the databases of CINAHL, ProQuest 
Nursing & Allied Health Sources and PubMed. The terms searched while researching this topic 
included: women, autoimmune, prevalence, and sex disparity. Results revealed that the sex 
disparity in autoimmunes are due to immunity interaction with female hormones, the presence of 
a double X chromosome, and immune response variation between males and females making 
their predisposition complex. With alteration of ICD codes to include contributing autoimmune 
disorders in death, the true burden of mortality that women face was revealed highlighting the 
need for further emphasis and research on this topic. Due to the limited research and knowledge, 
nurses need to be advocates for their female patients as they play a vital role in educating women 
on their risk and reducing their disease progression.  
 Keywords: women, autoimmune, prevalence, sex disparities, rise  
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Chapter 1: Introduction 
Background and Significance 
In the past two decades, the rates of autoimmune diseases have expanded exponentially. 
Presently, they account for the third most common category of disease in the United States 
affecting approximately 5 to 8% of the total population (Fairweather & Rose, 2004). This type of 
diverse disease, first described by Ian Mackay and Macfarlane Burnet, is characterized by a 
dysfunction in the immune system causing a failure of an organism to tolerate its own cells 
resulting in an abnormal immune response by lymphocytes and/or antibodies (Ngo, Steyn & 
McCombe, 2014).  
Autoimmunity results from an inflammatory state as the body attacks its own cells 
causing damage throughout the body's tissues and organs. In these diseases, the body literally 
invades itself, causing an inflammatory state while damaging its own tissues and organs at every 
site in the body (Fairweather & Rose, 2004). This response can either be classified as organ 
specific or systemic depending on the nature of the inflammatory process and cells that the body 
deems as “nonself” (Ngo et al, 2014). This state causes its host homeostatic dysfunction resulting 
in debilitating symptoms for the individual (Mallampalli, Davies, Wood, Robertson, Polato, & 
Carter, 2013). In turn the individual is left with lifelong disabilities and a substantial health and 
financial burden due to the chronic nature of these diseases and associated comorbidities 
(Mallampalli et al, 2013). 
The exact cause of autoimmune disorders has not yet been determined. Current research 
widely identifies that autoimmune dysfunction develops as a result of genetically susceptible 
individuals becoming exposed to environmental agents which trigger the onset of disease (Ngo et 
al, 2014). Each one of the nearly 80 identified autoimmune disorders have been shown to have 
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strong association with genetic variability in the human leukocyte antigen gene in combination 
with small effects on other genes contributing to the increased genetic susceptibility of certain 
individuals (Ngo et al, 2014). This genetic component can attribute to the incidents of 
autoimmune related diseases in families as a result of the interaction of common genes, 
accounting for an increase in an individual's genetic susceptibility (Ngo et al, 2014). Recent 
epidemiological trends in the incident rates also indicate a strong environmental cause, since 
large changes in rates over short periods of time cannot be explained by genetics alone 
(Mallampalli et al, 2013). The risk of specific autoimmune diseases such as systemic lupus 
erythematosus or Graves’ disease, have been linked to such environmental agents such as silica, 
pesticides and cigarette smoking (Mallampalli et al, 2013). The link between environmental 
exposure and autoimmune dysfunction has been proven in many studies yet, the exact 
mechanism of how this correlates is not fully understood (Mallampalli et al, 2013). Thus, it can 
be concluded that both genetic and environmental factors play a role in an individual's 
susceptibility in the development of one of these diseases.  
But how does having two X chromosomes play a role? When examining incidence rates 
of autoimmune disease over a population, there is a profound sex disparity. 78% or 6.7 million of 
those diagnosed with autoimmune related disorders are women (Fairweather & Rose, 2004). 
Collectively, autoimmune diseases account for the fifth leading cause of death to women under 
the age of 65 (Mallampalli et al, 2013). Most notable are systemic lupus erythematosus, 
rheumatoid arthritis, multiple sclerosis and thyroid related diseases, which are diagnosed in 
women at a 9-10 times greater rate than men. As noted before, current research suggests that 
autoimmune diseases arise from the interplay between an individual's genetic susceptibility and 
environmental agents, yet neither of these causes can explain the role of sex and gender influence 
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of the mechanisms leading up to an autoimmune disorder (Mallampalli et al, 2013). While 
autoimmune related disorders have been rising in the last decades, the understanding of their 
prevalence and incidence is still unknown (Mallampalli et al, 2013).  
Problem Statement 
Despite researchers knowing of the female prevalence of autoimmune related disorders 
for the past 100 years, only recently has attention been paid as to why this occurs (Whitacre, 
2001). When first discovered due to their rarity, autoimmune related disorders were looked at 
individually, as research tended to focus on questions pertaining to specific disease related 
mechanisms (Whitacre, 2001). With recognition that these disorders are collectively linked, the 
true extent of the sex disparity in autoimmunes was accepted. Presently, a knowledge gap still 
exists as to why there is a sex disparity in autoimmune related disorders. With the rates of 
autoimmune disorders rising in women, there is currently no conclusive research to suggest why 
this is. These diseases collectively result in a major public health problem due to their chronic 
nature which in turn increases societal burden in terms of healthcare costs, work productivity and 
reduced quality of life (Mallampalli et al, 2013).  Due to this lack of research, the collective 
disease burden associated with autoimmunes on women is also unknown (Thomas, Griffiths, 
Smeeth, Rooney, & Hall, 2010). The proposed integrative review study has the potential to 
determine the nature of the sex disparity in autoimmunes and understand the collective burden of 
these disorders. 
Purpose of the Integrative Literature Review   
  The purpose of this intended integrative literature review is first to determine the sex 
disparity between men and women in the development of autoimmune related disorders. This 
will help advance interventions and knowledge to decrease the likelihood of development of 
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such disease. The second purpose is to determine the collective burden that these disorders place 
on women. Research literature focusing on the specific aspects of the female sex in the role of 
autoimmunity will be analyzed and their findings will be reported. From this review, the 
interventions to reduce the prevalence of autoimmunes will be addressed as well as any need for 
further research and modification of research to reduce the prevalence of these diseases in 
women. The literature will allow women to be aware of their overall increased risk of 
autoimmune related disorders and specific factors that individually place them at an increased 
risk. The literature review also will provide information on the overall increased burden that 
autoimmune related disorders have on women.  
Research Questions 
1. What evidence has been collected to determine the sex disparity in autoimmune related 
disorders?  
2. What is the burden that women face when diagnosed with an autoimmune related disorder? 
3. What is being done to decrease the rates of autoimmune diseases in women? 
Conceptual Framework 
 The lack of research and attention paid to the sex disparity difference between men and 
women’s rates of autoimmune disorders may be due to the lack of female specific health 
education, prevention and promotion in regards to these disorders. The conceptual framework 
used to demonstrate the possible lack of attention to this subject is best described through The 
Tannahill Model (Figure 1). The model created by Andrew Tannahill in 1980 consists of three 
overlapping spheres of activity health education, prevention and health protection (Tannahill, 
2009). Health education is designed to change the knowledge, beliefs, attitudes, and behavior in 
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a way that facilitates health (Tannahill, 2009). Prevention aims at ways to decrease risk factors 
and minimize the consequences of disease and protection focuses on legal controls and policies 
aimed at preventing ill-health and enhancing well-being (Tannahill, 2009). In this review, the 
focus is on health education to change the knowledge of women’s risk of autoimmune related 
disorders as well as prevention to decrease the sex disparity and minimize the health burden 
placed on women when they are diagnosed with autoimmune related disorders. Thus, the model 
presented in figure 1 works best for the purposes of the literature review being conducted.  
  
Figure 1: Conceptual Map Rates of Autoimmune Disease in Women  
Tannahill, A. (2009). Health Promotion: The Tannahill model revisited. Public Health, 
123(5), 396-399. 
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Chapter 2: Methods 
Research Design 
The design of the study presented here is an integrative literature review aimed to 
discover the evidence that has been collected to determine the sex disparity in autoimmune 
related disorders and to determine the burden that women face when they are diagnosed with an 
autoimmune disorder. In order to complete the integrative literature review, the researcher of this 
study will conduct a search of literature to find articles on studies that have been conducted that 
are appropriate for the criteria listed below. The integrative literature review will be conducted 
following the framework of Whittemore and Knalf (2005).  
The review will include the stages of an integrative review including problem 
identification, literature search, data evaluation, data analysis and presentation. Themes from this 
analysis will be evaluated with current literature to support and confirm the current research 
regarding women and autoimmune disorders. The information from this review can be used to 
provide education to women in regards to their increased risk of autoimmune disorders and bring 
to light the collective burden related to a diagnosis.  
Literature Search Strategies  
 For this integrative literature review, the DePaul and Rosalind Franklin University's 
search engines were utilized in order to access library databases. To gather sources for this 
integrative literature, review the following databases were searched: CINAHL, ProQuest Nursing 
& Allied Health Sources and PubMed. The keywords that were used to search the previously 
mentioned databases were “women” and “autoimmune” and “prevalence” which yielded eight 
sources. Other keywords that were used to search the databases to yield additional articles were 
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“sex disparity” and “autoimmune” which yielded another four sources. One article retrieved 
from PubMed, which was relevant to this literature review suggested several other studies the 
conducted research on the prevalence of autoimmune disorders in women that were useful for 
this literature review. When searching the terms, the majority of the research came from journals 
regarding women’s health and included a lot of significant information regarding the literature 
review.  
Literature Search Limitations and Inclusion/ Exclusion Criteria 
 The search for the integrative literature review was limited to journal articles published 
between 1995-2016. Initially, a search was generated using the keywords “women” and 
“autoimmune” and “prevalence” returning 9389 results. From this initial search the term “sex 
disparity” was added resulting in 564 results of which eight sources were yielded. Another 
search was conducted using the key terms “sex disparities” and “autoimmune” which yielded 
883 results. When including the keyword “rise” 331 articles resulted in which four articles were 
picked. Several articles were also included that were suggested research based on the initial 
article included. Studies which did not focus on the link between women and autoimmune 
disorders and their collective burden, were excluded, limiting the relevant sources to 15 articles 
that discuss the cause of the rising rates of autoimmune disorders in women and their collective 
disease burden. See Figure 2 in appendix for diagram of review process.  
Data Analysis  
 The studies that will be included will be organized into a table in which the articles will 
be under the following categories that discuss women and autoimmune diseases: author and year; 
design, sample and location, aim of study, outcome measures, study results, and study 
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conclusions. The various studies will be compared and contrasted based on their findings as to 
the link between autoimmune disorders and sex. Studies presented in the literature review will 
explore the sex disparity in autoimmune disorders, current methods of prevention and the 
collective burden of these disorders on women.  
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Chapter 3: Results 
 A synthesis across studies in the review of literature in relation to autoimmune disorders 
and sex disparities and the collective disease burden on women were analyzed. The chart matrix 
will be used in order to evaluate the studies that will be used in the systematic literature review 
and to close the knowledge gap which exists as to why there is a sex disparity related to 
autoimmune disorders. With the rise of autoimmune disorders, education and collective disease 
burden of these disorders need to be determined. As stated in the study by Quintero, et al (2011) 
women are at a 2.7 times greater risk of acquiring AD’s than men as they also tend to have a 
different age of onset related to reproductive ages coinciding when hormone levels begin to rise 
and different disease activity. Another study conducted revealed that with new research showed 
that in the UK, autoimmune disorders are a major cause of mortality among females appearing 
among the 10 most frequent underlying causes of death while also estimating the contribution of 
these disorders to mortality (Thomas et al, 2010). Furthermore, an overall trend in the articles 
proved that by grouping autoimmune disorders together helps identify the full extent of the sex 
disparity, promote research and identify common determinants for prevention strategies (Thomas 
et al, 2010).  
Discussion 
Hormones 
 The first theory as to why there is such a higher prevalence of AD’s in women began to 
form in 1978 when researchers targeted estrogen in mice as a possible factor that increased a 
woman’s susceptibility to these disorders (Squires, 1995). In their study, researchers removed the 
gonads in mice and then gave them either testosterone or estrogen exclusively (Squires, 1995). 
The results showed that mice who received testosterone were protected from AD’s, whereas the 
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mice who received estrogen developed AD’s at a higher rate (Squires, 1995). More recently, 
female sex hormones such as estrogen, prolactin, leptin and androgens (testosterone) have all 
been examined to determine the exact hormonal role into the development of AD’s due to their 
capacity of modulating the immune response via androgen and estrogen receptors (Quintero et al, 
2011). In the case of estrogen, the hormone has been shown to direct the immune system to favor 
a more T-helper 1 (Th1) lymphocyte domination causing more B cell activation and antibody 
production (Quintero et al, 2011). In addition, estrogen acts as an immune- stimulator by 
affecting maturation and selection of autoreactive B cells and autoantibody secretion (Quintero et 
al, 2011). When administering estradiol into to animal models, the results show an increased the 
number of IgE production and induced specific anti-DNA antibody secretion (Moroni, 2012). 
Estrogen also affects proinflammatory cytokine synthesis, as it is enhanced in the presence of the 
hormone (Whitacre, 2001). This can be seen in the example of systemic lupus erythematosus 
(SLE), which has a significant predominance in women (Quintero et al, 2011). In SLE, there is 
an imbalance between the hormone relationship resulting in lower immune-suppressive 
androgens and higher immune enhancing estrogens (Quintero et al, 2011). When estrogen levels 
are high such as in the case of pregnancy, SLE tends to worsen for women displaying the impact 
of estrogen on immunity (Quintero et al, 2011).  
 Other hormones that play a role in predisposing women to AD’s are prolactin and leptin. 
Like estrogen, prolactin acts as an immune stimulator affecting B cells and autoantibody 
secretion (Quintero et al, 2011). Prolactin reconstitutes humoral and cell mediated immune 
responses and are greater in females as a result of the effects of oestrogens (Da Silva, 1995). 
Prolactin has been shown to enhance autoimmunes worsening disease severity (Ngo et al, 2014). 
Leptin, in conjunction with estrogen has shown to also play a role in the development of 
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autoimmunity as it is a potent modulator of the immune response (Merrill, 2015). Specifically, 
leptin has been linked to the initiation of autoimmune thyroid disease as it has a direct effect on 
the thyroid through inflammatory molecules (Merrill, 2012). With an increased level of leptin, 
there is enhanced inflammation creating the foundation for thyroid autoimmunity (Merrill, 
2012). These two hormones like estrogen that are increased in women, play a role in the 
enhancement of the overall immune response giving more opportunity for the development of an 
autoimmune response. 
 The last hormone affects the chances of autoimmune development are androgens. 
Androgens in contrast with the other hormones mentioned above are commonly associated with 
the development of masculine characteristics, as they are high in males and remain at a low level 
throughout a female's lifetime (Ngo et al, 2014). Like estrogen, androgens affect the immune 
system, such as testosterone which reduces the proliferation and differentiation of lymphocytes 
as well as inhibits the cytotoxic activity of NK cells (Ngo et al, 2014). These findings coupled 
with the reduced rates of autoimmunity in males show that androgens may play a protective role 
in autoimmunity (Da Silva, 1995). Despite the many hormonal influences that impact the 
immune system, the main female, estrogen and male, testosterone hormones have a large role in 
determining one’s predisposition to the development of an autoimmune.  
The X Factor 
 The second mechanism proposed as to why AD’s are more prevalent in females traces 
back to the very reason that a human is female or male, the presence of XX or XY. Contrasting 
the Y chromosome, which has many fewer genes, the X chromosome contains over 1000 genes 
that are essential to cell development and viability (Quintero et al, 2012). During early female 
development, one of the x chromosomes and its genes, is inactivated to balance the amount of X 
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chromosomal genes in females (Dai & Ahmed, 2014). Despite this precision, this process is not 
always 100% accurate as 15% of the X chromosome linked genes escape, allowing expression 
on both copies of the X chromosomes to be present (Dai & Ahmed, 2014). Since many of the 
immune related genes are located on the X chromosome, the differential expression, 
overexpression, and/ or mutation of these one or both of these genes contribute to the sex 
differences in immune response (Dai & Ahmed, 2014). For example, the gene Foxp3 is located 
on the arm of the X chromosome and is essential for T cell regulation (Moroni et al, 2012). A 
deficiency or mutation in this gene can lead to early onset, highly aggressive, and often fatal 
multiorgan AD’s (Moroni et al, 2012). Environmental agents that cause demyelination of the X 
chromosome can also contribute to a defective gene mutation causing T cell overexpression, 
autoreactivity and cytotoxic proinflammatory properties again leading to the development of 
AD’s (Mallampalli et al, 2013). An additional mechanism of skewed X chromosome inactivation 
during early development could also possibly lead to inactivation of genes that protect against 
autoimmunity or the overexpression of a susceptibility gene leading to an increase in AD 
predisposition (Quintero et al, 2012). These combined elements influencing the X chromosome 
and its gene expression result in the increased likelihood and predisposition that women have 
towards developing an autoimmune.  
Immune Differences 
 The final key aspect in determining why there is such an increased rate of autoimmunes 
in women, emanates from the difference in immune response in the sexes. Overall, women 
respond to infection, vaccination, and trauma with increased antibody production, whereas in 
men, inflammation becomes more severe resulting in an increased mortality (Fairweather et al, 
2008). Despite this increased antibody production, which protects women against infection, it is 
RATES OF AUTOIMMUNE DISEASE IN WOMEN 17 
a double-edged sword when it comes to the development of autoimmunity (Fairweather et al, 
2008). With an increased antibody response, there is an increased risk of developing an 
autoimmune disorder as the number of autoantibodies present in an individual is a good predictor 
and escalates the risk of developing an AD (Fairweather et al, 2008). Additionally, with more 
antibody activation, T cell activation is more vigorous and women have a higher absolute 
number of CD4 lymphocytes (Fairweather et al, 2008). The number of antibodies, extreme T cell 
activation and higher number of CD4’s all are contributing factors to the increased immune 
response seen during an autoimmune disorder (Whitacre, 2001). This increased immune 
reactivity and greater immunocompetence found in women make them more prone to developing 
autoimmune disorders, which could account for the overall higher rates of the disorder (Ngo et 
al, 2014).  
Finally, the role of miRNA also contributes to the difference in sex immunity. miRNA 
are a group of endogenously expressed, small, non-protein coding RNAs that regulate gene 
expression post transcriptionally and have different patterns of expression between males and 
females in the context of autoimmunes (Dai & Ahmed, 2014). This difference in expression of 
immune cells which regulate immune- linked genes, leads to the difference in disease 
susceptibility and severity between males and females (Dai & Ahmed, 2014). Environmental 
stimuli and pathological changes alter the expression of these miRNAs, for example, ionizing 
radiation, which can alter the downregulation of some miRNAs in women, but have no effect in 
males (Dai & Ahmed, 2014). The regulation of specific miRNAs on immune function is not fully 
understood despite several studies showing the differences of their expression between the sexes, 
thus more research needs to conducted to fully understand the role they play in autoimmunity 
(Dai & Ahmed, 2014). The combination of all these factors, antibodies, T cells, CD4 and 
RATES OF AUTOIMMUNE DISEASE IN WOMEN 18 
miRNA in women, cause a greater risk of developing autoimmunes based on the delicate balance 
and higher reactivity that the immune system must maintain. 
Collective Burden on Women 
 Now that contributing factors behind the increased susceptibility of women to ADs have 
been determined, the collective burden that these increased rates have on them can be 
established. As mentioned before, the consequence of diagnosis of an autoimmune result in 
chronic ill health, poor quality of life and major health care costs (Thomas et al, 2010). These 
factors place an enormous burden on their hosts, which are predominantly women. In attempt to 
determine this collective burden, two separate studies examined death certificates, one from the 
US and one from the United Kingdom, to determine if alteration of ICD codes for underlying 
contributing autoimmune disorders would affect the ranking of the top official leading causes of 
death (Walsh & Rau, 1995). Current ICD classifications are limited and do not account for 
autoimmunes because disorders are listed under separate organ systems (Thomas et al, 2003). In 
1995, US results showed that within two groupings of ADs, autoimmune related deaths exceeded 
the count for the 10th leading cause of death in all age groups younger than 65 (Walsh & Rau, 
1995). Similar results were found in the UK from 2003, where autoimmunes were ranked as the 
7th leading cause of death for women between the ages of 1-54 (Thomas et al, 2010). The 
limitation in classification of ICD codes have essentially hidden the combined burden of 
mortality for women due to autoimmunes due to their limited classification (Thomas et al, 2003). 
This is important because ICD rankings are the source of important information for health 
policymakers and those responsible for delivering health care, as well as highlight areas for 
further research on treatment and prevention on conditions (Thomas et al, 2003). Without 
recognition that ADs are a major leading cause of death for women, further research and 
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exploration in treatment and prevention will not be conducted and the burden of ADs on women 
as well as the healthcare system will rise (Thomas et al, 2003). Autoimmunes remain neglected 
in the ICD ranking lists and collective impact of autoimmune disorders on female health will 
continue to be masked (Thomas et al, 2003).  
Conclusion 
 Based on the proposed literature review, it is apparent that the etiology behind the 
increased rates of autoimmunes in women is complex. There is not a definitive cause or 
contributing factor that predisposes women to this increased risk of their development, rather the 
inner workings of hormones, the double X chromosome, and the variation between immune 
response seen in women combined creates the ideal conditions for autoimmunity to develop. 
Based on multiple studies, researchers have determined that the interaction between hormones 
and the immune system is the most convincing theory to date to explain the sex difference in 
AD’s having a strong influence on predisposition based on the rates (Quintero et al, 2012). 
Although not discussed, genetics factors outside of the X chromosome and the environment can 
also trigger the onset of an autoimmune and further research is needed in order to determine their 
interaction with the elements discussed above (Quintero et al, 2012). Major understanding of the 
hormonal, genetic and epigenetic process related to sex differences in AD’s may gain further 
insight into answering the questions proposed as AD’s continue to be a leading cause of death 
among young and middle aged women (Quintero et al, 2012). By grouping AD’s together, rather 
than looking at each individually, emphasis will be placed on their shared pathogenesis bringing 
to light the true burden of these disorders on women and promote research needed to identify 
common determinants (Thomas et al, 2010). Finally, research is needed to explore the opposite 
conclusions, why are autoimmunes less prevalent in males and could there be a factor that is 
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protective to explain this phenomenon (Quintero et al, 2012).  
Future Directions and Nursing Limitations 
The current body of research regarding sex and autoimmunity is very limited and vague. 
More research is needed to understand the extent of the sex differences in AD’s and their 
etiology to begin to develop new treatments to suppress the progression of these disorders 
(Whitacre, 2001). New findings from researchers at Ohio State have suggested and began to test 
a new type of treatment known as oral tolerance therapy, which targets the destructive cell lines 
that turn off the destructive part of the immune system and reduce attacks on the brain tissue in 
MS patients (Squires, 2016). More emphasis on this type of research in sex differences and 
autoimmune treatments needed to be encouraged in order to gain advancements in this field to 
identify further prevention strategies (Thomas et al, 2010).  
Regardless of the etiology of the development of an autoimmune, results from alteration 
of ICD codes show that AD’s constitute a major public health issue for women (Thomas et al, 
2010). Nurses play a vital role in identifying and educating women who have an increased risk of 
the development of autoimmunes in order to reduce their chances of progression. Due to the 
limited research and knowledge that is available on these disorders, nurses need to be advocates 
for their female patients, encouraging them to seek the highest level and most appropriate care 
for treatment. This includes advocating for expert opinions on rare disorders in account of the 
burden of mortality that women face once diagnosed (Thomas et al, 2010). In addition to 
educating their patients, nursing as a profession needs to be educated regarding the disparity of 
autoimmunes between the sexes so that they can properly treat patients as well as help advocate 
for more research in this field. Since the 1970s when the difference in autoimmunity between the 
sexes was first identified, major progression in research has been made in identifying factors that 
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contribute to this discrepancy (Squires, 2016). More extensive studies are needed to identify 
treatment options that will reduce the effect of the identified factors which predispose women to 
developing autoimmunity.   
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Appendix 
Figure 2: Diagram of Review Process  
A diagram was created to display the process used to review the articles selected and 
studies that were included. This method enables readers to reproduce the search results and gain 
knowledge into the methods used to obtain information about this research topic. An initial 
diagram is depicted below in Figure 2. 
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Figure 2: Diagram of Review Process and Study Selection.  
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Fairweathe
r and N. 
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(2004) 
Literature 
Review 
 
Johns 
Hopkins 
University 
Baltimore, 
Maryland 
To determine 
the link 
between high 
incidences of 
autoimmunes 
in women and 
families with 
possible 
precursor 
inducing 
infectious 
agents. 
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response to CB3 
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the stimulation of 
male and female 
innate immune 
response by 
pathogens must be 
studies as well as 
more clarification as 
to the male versus 
female differences 
in the adaptive 
immune response. 
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C. et al 
(2010) 
Analysis of 
1993-2003 
death 
certificates 
that listed 
autoimmune 
conditions as 
underlying or 
contributory 
causes of 
death. 
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Reviewed 
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based studies 
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associated. 
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from 
autoimmune 
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limited 
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gap in the 
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possible 
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for sex specific 
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possible 
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differences in 
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vulnerability, 
reproductive 
capacity with 
pregnancy, sex 
hormones, 
genetic 
predisposition, 
parental 
inheritance and 
epigenetics. 
Evidence 
demonstrates 
that gender and 
sex have a 
significant 
influence on 
the 
development 
of an 
autoimmune 
disease. . 
Considerations of 
gender should be at 
the forefront of all 
studies that attempt 
to define 
mechanisms the 
underpin 
autoimmune 
disorders. 
L. Moroni, 
I. Bianchi, 
and A. 
Lleo 
(2012) 
Literature 
Review, 
Survey of 
Geological 
Area 
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Clinico 
Humanitas, 
Razzano, 
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Describe geo 
epidemiologica
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related to the 
study of 
autoimmune 
conditions and 
its female 
prevalence. To 
attempt to 
focus on the 
critical issues 
of the lack of 
knowledge of 
the mechanism 
of influence. 
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distribution of 
autoimmunes 
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global regions 
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of 
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and advance the 
understanding of 
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higher rates of 
autoimmunes 
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environmental 
factors, sex 
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the presence of 
the extra X 
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complications and 
to develop novel 
therapeutic 
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latest research to 
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could be the 
cause of these 
higher rates of 
autoimmunes in 
women. 
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protect women 
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autoimmune 
disorders as 
pregnancy can 
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protective 
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is more lenient 
on detecting 
foreign 
invaders. 
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as oral tolerance 
therapy has been 
tested in mice and 
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can turn off the 
destructive part of 
the immune system 
and reduce the 
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be a promising new 
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D. 
Fairweathe
r, S. 
Frisaancho-
Kiss, and 
N. Rose 
(2008) 
Review 
 
Johns 
Hopkins 
Medical 
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Baltimore 
Maryland 
Discusses the 
distribution of 
autoimmune 
disease based 
on sex and age 
showing the 
autoimmune 
disease 
progress from 
an acute 
pathology 
associated with 
an 
inflammatory 
immune 
response to a 
chronic 
pathology. 
Examine the 
distinction 
between acute 
and chronic 
pathology as it 
impacts the 
understanding of 
sex differences 
in autoimmune 
diseases. 
There is a 
difference 
between Th1 
and Th2 
mediated 
pathology 
when looking 
at the 
distribution 
between males 
and females. 
Females have 
an increased 
incidence 
appearing 
chronically 
later in life 
when chronic 
pathology, 
fibrosis and 
increased 
numbers of 
autoantibodies 
are present. 
Due to the fact that 
there is a difference 
between acute and 
chronic phases of 
disease are 
regulated differently 
in males females, 
distinguishing these 
two pathological 
phases in animal 
models and patients 
could lead to more 
effective treatments. 
O. 
Quintero, 
M. 
Amador-
Patarroyo, 
G. 
Montoya-
Ortiz, and 
A. Rojas-
Villarraga 
Literature 
Review 
 
Universidad 
del Rosario, 
Bogotá, 
Colombia 
To determine 
the exact 
causes in the 
differences in 
autoimmune 
trends seen 
between men 
and women. 
Examine the 
exact differences 
in hormonal 
influence on the 
immune system 
as well as how 
specific female 
hormones 
influence 
autoimmune 
Autoimmunes 
are complex 
and 
multifactorial 
entities which 
genetic, 
epigenetics and 
hormonal 
differences 
strongly 
The more frequent 
the autoimmune is 
and later it shows up 
the more women are 
affected. Additional 
efforts need to 
explore why AD’s 
are prevalent in 
males and if there is 
a group of 
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